JP2015517484A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517484A5 JP2015517484A5 JP2015510875A JP2015510875A JP2015517484A5 JP 2015517484 A5 JP2015517484 A5 JP 2015517484A5 JP 2015510875 A JP2015510875 A JP 2015510875A JP 2015510875 A JP2015510875 A JP 2015510875A JP 2015517484 A5 JP2015517484 A5 JP 2015517484A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- sequence
- peptide
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1208293.9 | 2012-05-11 | ||
| GB201208293A GB201208293D0 (en) | 2012-05-11 | 2012-05-11 | Hydrochlorice salt of peptide |
| PCT/GB2013/051201 WO2013167897A1 (en) | 2012-05-11 | 2013-05-09 | Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517484A JP2015517484A (ja) | 2015-06-22 |
| JP2015517484A5 true JP2015517484A5 (enExample) | 2016-06-30 |
| JP5982562B2 JP5982562B2 (ja) | 2016-08-31 |
Family
ID=46396890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015510875A Expired - Fee Related JP5982562B2 (ja) | 2012-05-11 | 2013-05-09 | ペプチドの塩酸塩及び他のペプチドとの併用によるその免疫治療用途 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9657061B2 (enExample) |
| EP (1) | EP2847209B8 (enExample) |
| JP (1) | JP5982562B2 (enExample) |
| KR (1) | KR20150014955A (enExample) |
| CN (1) | CN104428311B (enExample) |
| AU (1) | AU2013257784A1 (enExample) |
| BR (1) | BR112014028130A2 (enExample) |
| CA (1) | CA2873120A1 (enExample) |
| EA (1) | EA201492068A1 (enExample) |
| GB (2) | GB201208293D0 (enExample) |
| HK (1) | HK1201850A1 (enExample) |
| IL (1) | IL235388A (enExample) |
| IN (1) | IN2014DN09367A (enExample) |
| MX (1) | MX2014013394A (enExample) |
| SG (1) | SG11201407446TA (enExample) |
| WO (1) | WO2013167897A1 (enExample) |
| ZA (1) | ZA201408290B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| SI3616706T1 (sl) | 2014-12-23 | 2021-12-31 | Immatics Biotechnologies Gmbh | Novi peptidi in kombinacija peptidov za uporabo v imunoterapiji proti hepatocelularnem karcinomu (HCC) in drugim oblikam raka |
| GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| ES2970246T3 (es) | 2015-03-27 | 2024-05-27 | Immatics Biotechnologies Gmbh | Péptidos novedosos y combinación de péptidos para usarse en inmunoterapia contra diferentes tumores |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
| EP4021920A4 (en) * | 2019-08-26 | 2023-08-16 | Auro Peptides LTD | IMPROVED PROCESS FOR PRODUCTION OF ETELCALCETIDE HYDROCHLORIDE |
| TWI792442B (zh) * | 2021-07-23 | 2023-02-11 | 建誼生技股份有限公司 | 依特卡肽鹽酸鹽之製造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2469078A1 (en) * | 2001-12-05 | 2003-06-12 | Circassia Limited | Immunotherapeutic methods and systems |
| AU2007207618B2 (en) * | 2006-01-18 | 2011-03-24 | Foresee Pharmaceuticals Co., Ltd. | Pharmaceutical compositions with enhanced stability |
| GB0710529D0 (en) * | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
| EP2397154B1 (en) | 2007-08-15 | 2015-07-15 | Circassia Limited | Peptides for desensibilization against allergens |
| GB2455108A (en) * | 2007-11-28 | 2009-06-03 | Circassia Ltd | T-Cell dependent method for detecting non-allergic or intrinsic disorders |
| GB0821806D0 (en) * | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
| WO2011121301A1 (en) * | 2010-03-31 | 2011-10-06 | Stabilitech Ltd | Excipients for stabilising viral particles, polypeptides or biological material |
-
2012
- 2012-05-11 GB GB201208293A patent/GB201208293D0/en not_active Ceased
-
2013
- 2013-05-09 CN CN201380036507.6A patent/CN104428311B/zh not_active Expired - Fee Related
- 2013-05-09 BR BR112014028130A patent/BR112014028130A2/pt not_active IP Right Cessation
- 2013-05-09 IN IN9367DEN2014 patent/IN2014DN09367A/en unknown
- 2013-05-09 EP EP13722023.2A patent/EP2847209B8/en not_active Not-in-force
- 2013-05-09 EA EA201492068A patent/EA201492068A1/ru unknown
- 2013-05-09 US US14/400,052 patent/US9657061B2/en not_active Expired - Fee Related
- 2013-05-09 AU AU2013257784A patent/AU2013257784A1/en not_active Abandoned
- 2013-05-09 KR KR20147034734A patent/KR20150014955A/ko not_active Withdrawn
- 2013-05-09 SG SG11201407446TA patent/SG11201407446TA/en unknown
- 2013-05-09 GB GB201421491A patent/GB2517354A/en not_active Withdrawn
- 2013-05-09 CA CA 2873120 patent/CA2873120A1/en not_active Abandoned
- 2013-05-09 WO PCT/GB2013/051201 patent/WO2013167897A1/en not_active Ceased
- 2013-05-09 JP JP2015510875A patent/JP5982562B2/ja not_active Expired - Fee Related
- 2013-05-09 HK HK15102275.5A patent/HK1201850A1/xx unknown
- 2013-05-09 MX MX2014013394A patent/MX2014013394A/es unknown
-
2014
- 2014-10-29 IL IL235388A patent/IL235388A/en not_active IP Right Cessation
- 2014-11-12 ZA ZA2014/08290A patent/ZA201408290B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015517484A5 (enExample) | ||
| NZ759512A (en) | Delayed release compositions of linaclotide | |
| PE20241305A1 (es) | Analogos de amilina | |
| PH12018550201A1 (en) | Hepatitis b antiviral agents | |
| JP2015078230A5 (enExample) | ||
| PH12018502465A1 (en) | Mic-1 compounds and use thereof | |
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| PH12020551118A1 (en) | Modified lipidated relaxin b chain peptides and their therapeutic use | |
| EA201391018A1 (ru) | Препараты иммуносупрессантов | |
| WO2015114395A9 (en) | Process for the preparation of vortioxetine salts | |
| PH12018501236A1 (en) | Pharmaceutical composition comprising a potent inhibitor urat1 | |
| JP2015513318A5 (enExample) | ||
| JP2020513418A5 (enExample) | ||
| EP4653537A3 (en) | Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function | |
| WO2013021284A3 (en) | Anti-il-6 vaccine composition | |
| MX2019003470A (es) | Composicion farmaceutica y metodo para el tratamiento de la enfermedad del higado graso no alcoholico. | |
| JP2018529626A5 (enExample) | ||
| WO2015024022A3 (en) | Designed peptides for tight junction barrier modulation | |
| WO2012162637A3 (en) | Vaccine adjuvants from self-assembling peptides | |
| JP2013542196A5 (enExample) | ||
| JP2016160183A5 (ja) | 筋萎縮抑制剤及び筋萎縮抑制用飲食品 | |
| MY189021A (en) | Peptides and uses therefor as antiviral agents | |
| WO2016197042A8 (en) | Modified or targeted release formulations of linaclotide | |
| EA032385B9 (ru) | Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта | |
| JP2017007966A5 (enExample) |